Science Current Events | Science News | Brightsurf.com
 

Research shows how 'Mallard' dye fills need for speed

February 15, 2013
Scientists at the University of York have developed a new medical tool which could help surgeons carrying out complex procedures in the operating theatre.

Researchers have developed a dye which provides a quick and accurate method of checking heparin levels in the blood.

Heparin is an important anti-coagulant which has a significant role in major surgery. The scientists in the Department of Chemistry at York have used inspiration from biological systems to allow the dye to bind heparin even in highly competitive human serum.

In the laboratory, they have modified existing dyes which previously could not bind with heparin successfully under these challenging conditions. The modified dye, which has excellent sensing capacity for heparin pinpoints the anti-coagulant's level in human serum and has the potential to work more quickly than existing clinical methods for doing this.

The research, which was funded by the Biotechnology and Biological Sciences Research Council, is published in the Journal of the American Chemical Society.

Because the dye can rapidly detect heparin levels, the scientists have named it 'Mallard Blue'. It is the same shade as the livery of the A4 Pacific Mallard, which holds the world speed record for a steam locomotive, and is now preserved at the National Railway Museum in York.

Professor Dave Smith, of the Department of Chemistry at York who led the research said: "Our new dye allows the quantification of heparin in serum at clinically relevant levels and is the best in class for this application in terms of its ability to bind heparin strongly under really competitive biological conditions, and may improve on the currently used systems.

"We have named the dye 'Mallard Blue', after the record-breaking steam train, 'Mallard' which is housed in the railway museum here at York. Our dye is the same colour as the locomotive, and we believe it is similarly ground-breaking in its performance."

The York researchers worked with a team led by Sabrina Pricl at the University of Trieste who used high-level computer modelling to understand precisely how Mallard Blue binds to heparin so strongly.

The next stage in this research would involve the incorporation of this new dye into a device for simple bedside read-out of heparin levels in blood.

University of York


Related Heparin Current Events and Heparin News Articles


Combined strategies help patients with adverse heparin reaction before heart surgery
New evidence suggests that therapeutic plasma exchange and appropriate blood testing could help patients who are in urgent need of heart surgery, but have a history of an adverse reaction to the blood thinner heparin.

Some heparin-allergic patients could have urgent heart surgery sooner with combination of appropriate blood screenings and therapeutic plasma exchange
McMaster University researchers have found new evidence that suggests patients with a history of adverse reaction to the blood thinner heparin may be ready for urgent heart surgery sooner with a combination of appropriate blood screenings and therapeutic plasma exchange.

UBC researchers aim to simplify life saving drug
Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by developing a universal antidote.

Were clinical trial practices in East Germany questionable?
Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according to a paper published online in the Journal of Medical Ethics.

Bioinspired coating for medical devices repels blood and bacteria
From joint replacements to cardiac implants and dialysis machines, medical devices enhance or save lives on a daily basis. However, any device implanted in the body or in contact with flowing blood faces two critical challenges that can threaten the life of the patient the device is meant to help: blood clotting and bacterial infection.

Patient's question triggers important study about blood thinners
Physicians around the world now have guidance that can help them determine the best oral blood thinners to use for their patients suffering from blood clots in their veins, thanks to a patient of The Ottawa Hospital who asked his physician a question he couldn't answer.

Growth factors found in breast milk may protect against necrotizing enterocolitis
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal illness affecting up to 10% of premature infants, with a 30% mortality rate, and formula feeding has been identified as a risk factor for NEC.

Mechanical heart valves increase pregnancy risk
The fact that mechanical heart valves increase risks during and after pregnancy, has been confirmed by data from the ROPAC registry presented for the first time today in an ESC Congress Hot Line session by Professor Jolien W. Roos-Hesselink, co-chair with Professor Roger Hall of the registry's executive committee.

Best anticoagulants after orthopedic procedures depends on type of surgery
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up to individual clinicians.

The Lancet: New trial suggests cheaper drugs for common heart attack procedure could improve outcomes and save health budgets millions
A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment.
More Heparin Current Events and Heparin News Articles

Heparin

Heparin


Heparin

Target audience: Medical students, residents, healthcare workers, patients
Weekly updates? Yes
Multiple choice questions? Yes
Board review? Yes

Heparin-Binding Proteins

Heparin-Binding Proteins
by H. Edward Conrad (Author)


This book describes the complex structures of heparins and heparan sulfates (heparinoids) and how they are generated by their biosynthetic pathways. The book also details the methodologies for studying these structures and their cellular metabolism. Heparin-Binding Proteins introduces the general nature of interactions between heparinoids and proteins, and presents the role for these structures in their interactions with the proteins of the hemostatic mechanisms, fibroblasts growth factors, superoxide dismutase, and lipoproteins.

Key Features
* Covers cellular metabolism of heparinoid proteoglycans
* Written by a distinguished expert in the field of carbohydrate biochemistry
* Describes the roles of heparan sulfate proteoglycans...

Heparin:: Properties, Uses and Side Effects (Pharmacology - Research, Safety Testing and Regulation)

Heparin:: Properties, Uses and Side Effects (Pharmacology - Research, Safety Testing and Regulation)
by David E. Piyathilake (Editor), Rhong Liang (Editor)


Book annotation not available for this title.
Title: Heparin:
Author: Piyathilake, David E. (EDT)/ Liang, Rhong (EDT)
Publisher: Nova Science Pub Inc
Publication Date: 2011/11/01
Number of Pages: 332
Binding Type: HARDCOVER
Library of Congress: 2011034014

Heparin-Induced Thrombocytopenia, Third Edition Revised And Expanded

Heparin-Induced Thrombocytopenia, Third Edition Revised And Expanded


Taking stock of advances in clinical recognition, laboratory testing, and pharmacologic therapy as well as basic aspects of pathogenesis, the Third Edition of Heparin-Induced Thrombocytopenia reinforces its standing as the leading guide to accurate diagnosis and effective management of this complex condition. Featuring added chapters on bivalirudin and pediatric heparin-induced thrombocytopenia (HIT), this reference also updates all 20 chapters of the previous edition to regard anew such topics as management of HIT using direct thrombin inhibitors and the special problems of renal failure and cardiac surgery in HIT patients.

Heparin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References

Heparin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
by Icon Health Publications (Author)


This is a 3-in-1 reference book. It gives a complete medical dictionary covering hundreds of terms and expressions relating to heparin. It also gives extensive lists of bibliographic citations. Finally, it provides information to users on how to update their knowledge using various Internet resources. The book is designed for physicians, medical students preparing for Board examinations, medical researchers, and patients who want to become familiar with research dedicated to heparin.If your time is valuable, this book is for you. First, you will not waste time searching the Internet while missing a lot of relevant information. Second, the book also saves you time indexing and defining entries. Finally, you will not waste time and money printing hundreds of web pages.

Heparin-Induced Thrombocytopenia, Fifth Edition (Fundamental and Clinical Cardiology)

Heparin-Induced Thrombocytopenia, Fifth Edition (Fundamental and Clinical Cardiology)
by Theodore E. Warkentin (Editor), Andreas Greinacher (Editor)


Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this condition. Identifying key signs and symptoms and providing clear intervention strategies—including the use of alternative anticoagulants to manage critical circumstances—this is an essential resource for all clinicians and a "must" for hematology consultants. Heparin-Induced Thrombocytopenia, Fifth Edition explores: Clinical and laboratory studies on HIT The immune basis and pathogenesis, animal models, and laboratory testing for HIT...

Heparin - A Century of Progress: 207 (Handbook of Experimental Pharmacology)

Heparin - A Century of Progress: 207 (Handbook of Experimental Pharmacology)
by Springer Berlin Heidelberg


Heparins remain amongst the most commonly used drugs in clinical practice.  Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects...

Chemistry and Biology of Heparin and Heparan Sulfate

Chemistry and Biology of Heparin and Heparan Sulfate
by Hari G. Garg (Editor), Robert J. Linhardt (Editor), Charles A. Hales (Editor)


The chemistry, biochemistry and pharmacology of heparin and heparan sulfate have been and continue to be a major scientific undertaking - heparin and its derivative remain important drugs in clinical practice. Chemistry and Biology of Heparin and Heparan Sulfate provides readers with an insight into the chemistry, biology and clinical applications of heparin and heparan sulfate and examines their function in various physiological and pathological conditions. Providing a wealth of useful information, no other tome covers the diversity of topics in the field. Students, doctors, chemists, biochemists, and research scientists will find this book an invaluable source for updating their current knowledge of developments in this area.

*...

Mysterious Heparin, the Key to Open Heart Surgery

Mysterious Heparin, the Key to Open Heart Surgery
by W.C. Bigelow (Author)


One of the world's pioneering heart surgeons, Canada's W.G. Bigelow, explains the mysterious anticoagulant heparin, essential to open heart surgery, from its discovery at Johns Hopkins University in 1916 through its purification for human use, finally supplying the key that makes possible the definitive treatment of the most common cause of illness and death -- heart disease.

Heparin: Structure, Drug Delivery Applications and Clinical Outcomes (Pharmacology-Research, Safety Testing and Regulations)

Heparin: Structure, Drug Delivery Applications and Clinical Outcomes (Pharmacology-Research, Safety Testing and Regulations)
by Nicole B. Wilkinson (Editor)




© 2014 BrightSurf.com